Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients-MedSci.cn

Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients

Qin, WF; Du, ZL; Xiao, JF; Duan, HL; Shu, Q; Li, HM

Li, HM (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310052, Peoples R China.; Li, HM (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou 310052, Peoples R China.

PHARMACOGENOMICS, 2020; 21 (3): 209

Abstract

Aim: To evaluate the clinical benefits of implementing pharmacogenomics testing for Chinese pediatric patients. Materials & methods : Based on the......

Full Text Link